Literature DB >> 10704380

Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-alpha-galactosyl antibodies.

V L Pereira-Chioccola1, A Acosta-Serrano, I Correia de Almeida, M A Ferguson, T Souto-Padron, M M Rodrigues, L R Travassos, S Schenkman.   

Abstract

In the presence of sialic acid donors Trypanosoma cruzi acquires up to 10(7) sialic acid residues on its surface, in a reaction catalyzed by its unique trans-sialidase. Most of these sialic acid residues are incorporated into mucin-like glycoproteins. To further understand the biological role of parasite sialylation, we have measured the amount of mucin in this parasite. We found that both epimastigote and trypomastigote forms have the same number of mucin molecules per surface area, although trypomastigotes have less than 10% of the amount of glycoinositol phospholipids, the other major surface glycoconjugate of T. cruzi. Based on the estimated surface area of each mucin, we calculated that these molecules form a coat covering the entire trypomastigote cell. The presence of the surface coat is shown by transmission electron microscopy of Ruthenium Red-stained parasites. The coat was revealed by binding of antibodies isolated from Chagasic patients that react with high affinity to alpha-galactosyl epitopes present in the mucin molecule. When added to the trypomastigote, these antibodies cause an extensive structural perturbation of the parasite coat with formation of large blebs, ultimately leading to parasite lysis. Interestingly, lysis is decreased if the mucin coat is heavily sialylated. Furthermore, addition of MgCl2 reverses the protective effect of sialylation, suggesting that the sialic acid negative charges stabilize the surface coat. Inhibition of sialylation by anti-trans-sialidase antibodies, found in immunized animals, or human Chagasic sera, also increase killing by anti-alpha-galactosyl antibodies. Therefore, the large amounts of sialylated mucins, forming a surface coat on infective trypomastigote forms, have an important structural and protective role.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704380     DOI: 10.1242/jcs.113.7.1299

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  68 in total

1.  Epitope mapping of trans-sialidase from Trypanosoma cruzi reveals the presence of several cross-reactive determinants.

Authors:  T A Pitcovsky; J Mucci; P Alvarez; M S Leguizamón; O Burrone; P M Alzari; O Campetella
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Gene discovery in the freshwater fish parasite Trypanosoma carassii: identification of trans-sialidase-like and mucin-like genes.

Authors:  Fernán Agüero; Vanina Campo; Laura Cremona; Adriana Jäger; Javier M Di Noia; Peter Overath; Daniel O Sánchez; Alberto Carlos Frasch
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 3.  Sialoglycans in protozoal diseases: their detection, modes of acquisition and emerging biological roles.

Authors:  Anil K Chava; Sumi Bandyopadhyay; Mitali Chatterjee; Chitra Mandal
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

4.  Continuous nonradioactive method for screening trypanosomal trans-sialidase activity and its inhibitors.

Authors:  Paula A Sartor; Rosalía Agusti; Maria S Leguizamón; Oscar Campetella; Rosa M de Lederkremer
Journal:  Glycobiology       Date:  2010-04-07       Impact factor: 4.313

5.  Synthesis of PEGylated lactose analogs for inhibition studies on T.cruzi trans-sialidase.

Authors:  M Eugenia Giorgi; Laura Ratier; Rosalía Agusti; Alberto C C Frasch; Rosa M de Lederkremer
Journal:  Glycoconj J       Date:  2010-07-20       Impact factor: 2.916

6.  Free energy study of the catalytic mechanism of Trypanosoma cruzi trans-sialidase. From the Michaelis complex to the covalent intermediate.

Authors:  Gustavo Pierdominici-Sottile; Nicole A Horenstein; Adrian E Roitberg
Journal:  Biochemistry       Date:  2011-10-27       Impact factor: 3.162

7.  Identification of glycoproteins targeted by Trypanosoma cruzi trans-sialidase, a virulence factor that disturbs lymphocyte glycosylation.

Authors:  Romina P Muiá; Hai Yu; Jennifer A Prescher; Ulf Hellman; Xi Chen; Carolyn R Bertozzi; Oscar Campetella
Journal:  Glycobiology       Date:  2010-03-30       Impact factor: 4.313

8.  Evaluation of a recombinant Trypanosoma cruzi mucin-like antigen for serodiagnosis of Chagas' disease.

Authors:  Claudia R De Marchi; Javier M Di Noia; Alberto C C Frasch; Vicente Amato Neto; Igor C Almeida; Carlos A Buscaglia
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

9.  Anti-trypanosomatid activity of ceragenins.

Authors:  Diana Lara; Yanshu Feng; Julia Bader; Paul B Savage; Rosa A Maldonado
Journal:  J Parasitol       Date:  2010-06       Impact factor: 1.276

10.  Inhibition of proteasome activity blocks Trypanosoma cruzi growth and metacyclogenesis.

Authors:  Josiane Cardoso; Maurilio J Soares; Rubem F S Menna-Barreto; Rozenn Le Bloas; Vanessa Sotomaior; Samuel Goldenberg; Marco A Krieger
Journal:  Parasitol Res       Date:  2008-06-26       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.